• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤病中的EQ-5D:效度与反应度评估

EQ-5D in skin conditions: an assessment of validity and responsiveness.

作者信息

Yang Yaling, Brazier John, Longworth Louise

机构信息

Nuffield Department of Primary Care Health Sciences, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6NW, UK.

Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK.

出版信息

Eur J Health Econ. 2015 Dec;16(9):927-39. doi: 10.1007/s10198-014-0638-9. Epub 2014 Oct 31.

DOI:10.1007/s10198-014-0638-9
PMID:25358263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4646948/
Abstract

AIMS AND OBJECTIVES

This systematic literature review aims to assess the reliability, validity and responsiveness of three widely used generic preference-based measures of health-related quality of life (HRQL), i.e., EQ-5D, Health Utility Index 3 (HUI3) and SF-6D in patients with skin conditions.

METHODS

A systematic search was conducted to identify studies reporting health state utility values obtained using EQ-5D, SF-6D, or HUI3 alongside other HRQL measures or clinical indices for patients with skin conditions. Data on test-retest analysis for reliability, known group differences or correlation and regression analyses for validity, and change over time or responsiveness indices analysis were extracted and reviewed.

RESULTS

A total of 16 papers reporting EQ-5D utilities in people with skin conditions were included in the final review. No papers for SF-6D and HUI3 were found. Evidence of reliability was not found for any of these measures. The majority of studies included in the review (12 out of 16) examined patients with plaque psoriasis or psoriatic arthritis and the remaining four studies examined patients with either acne, hidradenitis suppurativa, hand eczema, or venous leg ulcers. The findings were generally positive in terms of performance of EQ-5D. Six studies showed that EQ-5D was able to reflect differences between severity groups and only one reported differences that were not statistically significant. Four studies found that EQ-5D detected differences between patients and the general population, and differences were statistically different for three of them. Further, moderate-to-strong correlation coefficients were found between EQ-5D and other skin-specific HRQL measures in four studies. Eight studies showed that EQ-5D was able to detect change in HRQL appropriately over time and the changes were statistically significant in seven studies.

CONCLUSIONS

Overall, the validity and responsiveness of the EQ-5D was found to be good in people with skin diseases, especially plaque psoriasis or psoriatic arthritis. No evidence on SF-6D and HUI3 was available to enable any judgments to be made on their performance.

摘要

目的与目标

本系统文献综述旨在评估三种广泛使用的基于偏好的健康相关生活质量(HRQL)通用测量工具,即EQ-5D、健康效用指数3(HUI3)和SF-6D在皮肤病患者中的可靠性、有效性和反应性。

方法

进行系统检索,以识别报告使用EQ-5D、SF-6D或HUI3获得的健康状态效用值以及其他HRQL测量工具或临床指标的皮肤病患者研究。提取并审查关于可靠性的重测分析数据、关于有效性的已知组差异或相关性及回归分析数据,以及随时间变化或反应性指标分析数据。

结果

最终综述纳入了16篇报告皮肤病患者EQ-5D效用值的论文。未找到关于SF-6D和HUI3的论文。未发现这些测量工具中任何一种的可靠性证据。综述纳入的大多数研究(16篇中的12篇)研究了斑块状银屑病或银屑病关节炎患者,其余4项研究研究了痤疮、化脓性汗腺炎、手部湿疹或下肢静脉溃疡患者。就EQ-5D的表现而言,研究结果总体呈阳性。6项研究表明EQ-5D能够反映严重程度组之间的差异,只有1项报告的差异无统计学意义。4项研究发现EQ-5D检测出患者与一般人群之间的差异,其中3项差异具有统计学意义。此外,4项研究发现EQ-5D与其他皮肤特异性HRQL测量工具之间存在中度至强的相关系数。8项研究表明EQ-5D能够随时间适当地检测HRQL的变化,7项研究中的变化具有统计学意义。

结论

总体而言,发现EQ-5D在皮肤病患者,尤其是斑块状银屑病或银屑病关节炎患者中具有良好的有效性和反应性。没有关于SF-6D和HUI3的证据可用于对其表现做出任何判断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c3/4646948/92fb72b0707e/10198_2014_638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c3/4646948/92fb72b0707e/10198_2014_638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c3/4646948/92fb72b0707e/10198_2014_638_Fig1_HTML.jpg

相似文献

1
EQ-5D in skin conditions: an assessment of validity and responsiveness.皮肤病中的EQ-5D:效度与反应度评估
Eur J Health Econ. 2015 Dec;16(9):927-39. doi: 10.1007/s10198-014-0638-9. Epub 2014 Oct 31.
2
How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.一般健康状况量表(如 EQ-5D 和 SF-36)在精神分裂症中的有效性和反应性如何?系统评价。
Value Health. 2011 Sep-Oct;14(6):907-20. doi: 10.1016/j.jval.2011.04.006. Epub 2011 Jul 28.
3
The Psychometric Performance of Generic Preference-Based Measures in Informal Carers: A Systematic Review of Validation Studies.通用偏好性测量工具在非正式照料者中的心理测量性能:验证研究的系统评价
Pharmacoeconomics. 2025 Jun 28. doi: 10.1007/s40273-025-01509-9.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
The impact of biological interventions for ulcerative colitis on health-related quality of life.溃疡性结肠炎生物干预措施对健康相关生活质量的影响。
Cochrane Database Syst Rev. 2015 Sep 22;2015(9):CD008655. doi: 10.1002/14651858.CD008655.pub3.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
9
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.CFQ-R-8D 与 EQ-5D-3L 和 SF-6D 在囊性纤维化患者中的心理测量性能比较。
J Patient Rep Outcomes. 2024 Feb 28;8(1):24. doi: 10.1186/s41687-024-00697-w.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension.使用移动辅助技术的弗里德赖希共济失调患者的健康相关生活质量:EQ-5D-3L移动维度的拟合度有限。
Neurol Ther. 2025 Feb;14(1):379-398. doi: 10.1007/s40120-024-00694-7. Epub 2024 Dec 30.
2
Qualitative evidence on EQ-5D-5L skin irritation and self-confidence bolt-ons in Darier's disease and Hailey-Hailey disease.关于达里埃病和黑利-黑利病中EQ-5D-5L皮肤刺激和自信心附加模块的定性证据。
Qual Life Res. 2025 Apr;34(4):977-989. doi: 10.1007/s11136-024-03871-1. Epub 2024 Dec 20.
3

本文引用的文献

1
A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.对心理健康人群健康通用偏好性测量指标的系统评价、心理测量分析和定性评估,以及从广泛使用的特定测量指标估计映射函数。
Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188. doi: 10.3310/hta18340.
2
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
3
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.
比较慢性皮肤病患者的EQ-5D-5L、PROPr、SF-6D和TTO效用值。
Eur J Health Econ. 2025 Jun;26(4):627-639. doi: 10.1007/s10198-024-01728-5. Epub 2024 Sep 28.
4
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT.螺内酯治疗女性持续性面部痤疮的临床疗效和成本效益:SAFA 双盲 RCT。
Health Technol Assess. 2024 Sep;28(56):1-86. doi: 10.3310/MYJT6804.
5
Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires.皮肤利什曼病患者的生活质量: EQ-5D-3L 和 CLIQ 问卷的对比分析。
PLoS One. 2024 Feb 23;19(2):e0298988. doi: 10.1371/journal.pone.0298988. eCollection 2024.
6
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.螺内酯治疗成年女性痤疮的成本效果分析(SAFA):一项随机对照试验的经济学评价。
BMJ Open. 2023 Dec 11;13(12):e073245. doi: 10.1136/bmjopen-2023-073245.
7
Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study.特应性皮炎患者皮肤刺激和自信附加物 EQ-5D-5L 的内容效度:一项定性出声思维研究。
Qual Life Res. 2024 Jan;33(1):101-111. doi: 10.1007/s11136-023-03519-6. Epub 2023 Oct 3.
8
Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L.健康相关生活质量在脊髓小脑共济失调患者中的研究: EQ-5D-3L 的验证研究。
Cerebellum. 2024 Jun;23(3):1020-1030. doi: 10.1007/s12311-023-01597-3. Epub 2023 Sep 15.
9
A network analysis of psychological flexibility, coping, and stigma in dermatology patients.皮肤病患者心理灵活性、应对方式和耻辱感的网络分析
Front Med (Lausanne). 2023 May 16;10:1075672. doi: 10.3389/fmed.2023.1075672. eCollection 2023.
10
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.了解欧洲营养不良性大疱性表皮松解症的社会经济成本:一项成本和健康相关生活质量研究。
Orphanet J Rare Dis. 2022 Sep 6;17(1):346. doi: 10.1186/s13023-022-02419-1.
Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.开发用于银屑病患者的 EQ-5D-5L 疾病专用版本:在英国进行可行性研究的经验教训。
Value Health. 2013 Dec;16(8):1156-62. doi: 10.1016/j.jval.2013.10.003. Epub 2013 Nov 11.
4
Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).开发和测试从特定疾病测量指标(和其他基于患者的结果测量指标)中推导出基于偏好的健康测量指标的方法。
Health Technol Assess. 2012 Jul;16(32):1-114. doi: 10.3310/hta16320.
5
A review of generic preference-based measures of health-related quality of life in visual disorders.视觉障碍相关健康相关生活质量的通用偏好测量的综述。
Value Health. 2012 Jan;15(1):118-27. doi: 10.1016/j.jval.2011.08.002. Epub 2011 Oct 1.
6
How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.一般健康状况量表(如 EQ-5D 和 SF-36)在精神分裂症中的有效性和反应性如何?系统评价。
Value Health. 2011 Sep-Oct;14(6):907-20. doi: 10.1016/j.jval.2011.04.006. Epub 2011 Jul 28.
7
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
8
Psychophysical aspects of hidradenitis suppurativa.化脓性汗腺炎的心理物理学方面。
Acta Derm Venereol. 2010 May;90(3):264-8. doi: 10.2340/00015555-0866.
9
Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.在银屑病关节炎中比较银屑病关节炎生活质量(PsAQoL)问卷、功能状态(HAQ)和效用(EQ-5D)测量:来自横断面调查的结果。
Scand J Rheumatol. 2010 Aug;39(4):303-9. doi: 10.3109/03009740903468982.
10
The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.在欧洲皮肤科诊所就诊的银屑病患者中,初始诊断银屑病后,发生银屑病关节炎的风险保持不变。
J Eur Acad Dermatol Venereol. 2010 May;24(5):548-54. doi: 10.1111/j.1468-3083.2009.03463.x. Epub 2009 Oct 23.